Our Multabody™ platform engages disease targets with unprecedented strength (high avidity) simultaneously across multiple pathways (multi-specific) within a single engineered molecule. This is particularly transformative in cancer and infectious diseases where we can direct immune cells to destroy tumors, block multiple disease pathways, or maintain therapeutic hold despite mutations or viral escape.